Trials / Completed
CompletedNCT03617419
Vscan Access R2 Feasibility Evaluation
Evaluation of Feasibility and Accuracy of Assisted Fetal Heart Rate (FHR) Feature of the GE Vscan Access R2 Ultrasound System
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- GE Healthcare · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study is being done to evaluate if the Vscan Access R2 Ultrasound System can measure Fetal Heart Rate (FHR) in humans when compared against a reference device (GE Corometrics 170 Series Fetal Monitor), and to gather feedback from device operators on the usability of the device.
Detailed description
This study is being done to evaluate whether the Vscan Access R2 Ultrasound System Assisted FHR phantom testing conclusions can be extrapolated onto human fetal heart rate measurements, where CTG (GE Corometrics 170 Series Fetal Monitor) is to provide a reference value. It should be noted that the Vscan Access R2 Ultrasound System with Assisted FHR has a different intended use than CTG (momentary FHR value versus continuous monitoring of FHR patterns and trends) and this aspect is out of scope of this research. Usability data will be gathered for further user experience optimization.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | GE VScan Access R2 Ultrasound System | A diagnostic ultrasound imaging system manufactured by the study Sponsor. |
| DEVICE | GE Corometrics 170 Series Fetal Monitor | A reference device to record a continuous fetal heart rate. |
| DEVICE | GE Corometrics 170 Series Fetal Monitor | A reference device for verification of scanning the fetal heart. |
Timeline
- Start date
- 2017-11-14
- Primary completion
- 2017-11-20
- Completion
- 2018-02-26
- First posted
- 2018-08-06
- Last updated
- 2019-07-11
- Results posted
- 2019-07-11
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03617419. Inclusion in this directory is not an endorsement.